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Abstract
Exposure to early life adversity may disrupt the development and maturation of neurons and brain 
circuits, which, in turn, underlie neurodevelopment and mental illnesses. During fetal life, 
maternal adversity is conveyed to the developing brain via several molecular signals, including the 
stress hormone corticotropin releasing hormone (CRH). Employing a large well characterized 
prospective cohort, we find that fetal exposure to placental-origin CRH levels predicts structural 
and functional brain outcomes in children. Specifically, elevated placental CRH levels portend 
thinning of selective cortical regions of exposed individuals, with commensurate cognitive and 
emotional deficits. Notably, the relations of placental-origin CRH to cortical thinning and 
childhood symptoms are sex-specific. In view of the established effects of CRH on survival and 
arborization of cortical neurons, these findings position placental CRH as an important mediator of 
the consequences of early-life adversity on neuropsychiatric outcomes.
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Introduction
Exposure to early life adversity disrupts brain development resulting in altered brain 
networks and structure (1–3). These structural changes are associated with functional 
alterations that are often maintained throughout the lifespan, mediated by enduring 
epigenetic modifications of gene expression (2–4). Indeed, enduring alterations of brain 
structure and function at molecular, cellular and circuit levels (5,6) are considered 
fundamental mechanisms of how early-life experiences influence health and disease (1–5). 
In the aggregate, exposures to intrauterine and neonatal insults (7) and consequent altered 
brain anatomy (8,9) and connectivity (10) contribute significantly to the global burden of 
mental illness.
Specifically, early-life exposure to maternal stress and trauma is linked to subsequent 
depression (11–13), posttraumatic stress disorder (PTSD), panic disorder, substance abuse, 
abnormal stress response (13,14) and other serious disorders (2,3,11). Emerging evidence 
suggests that exposure to early-life adversity may be causally related to brain changes 
underlying the risk for psychopathology (7,15,16). Because the fetal period is unmatched by 
any other in growth and development, this stage in the human life span is the most 
vulnerable to both organizing and disrupting maternal signals.
Among the most salient signals shaping the human fetus is the stress hormone, corticotropic-
releasing hormone (CRH). CRH, a 41-amino acid neuropeptide, is normally synthesized 
primarily in the paraventricular nucleus of the hypothalamus and has a major role in 
regulating pituitary-adrenal function and the physiological response to stress (17,18). CRH 
synthesized and released in other brain regions such as hippocampus (19) and cortex (20,21) 
contributes to the sculpting of neuronal dendritic development and maturation via its actions 
on specific receptors that are located on dendritic spines Indeed, nanomolar concentrations 
of CRH can excessively prune dendritic trees of developing rodent cortical neurons (22). 
CRH of brain origin is not detectable in the circulation (23). However, during human 
pregnancy, the CRH gene, located on the long arm of chromosome 8 (24), is expressed in the 
human placenta and amniotic membrane (25,26). Placental CRH (pCRH) is released into the 
maternal and fetal compartments as early as the eighth week of gestation and increases 
exponentially across gestation to regulate fetal maturation (27), metabolic functions (28,29) 
and the timing of birth (30).
Placental CRH expression is responsive to a range of maternal stress signals, including 
increased cortisol, norepinephrine and epinephrine, reduced uterine blood flow, and 
infection (31–33). Thus, placental CRH represents an integrative pathway through which 
diverse prenatal stressors inform the fetus of the state of its environment and shape fetal 
developmental trajectories in preparation for life after birth (34,35). There are several reports 
linking elevated human fetal exposure to pCRH including to decreased fetal startle and 
habituation (27,36), delayed neonatal neuromotor development (37); increased infant fear 
and distress (38); and prodromal markers of increased risk for affective disorders in young 
children (39). Here, we demonstrate the potential consequences of fetal exposure to elevated 
levels of CRH and identify putative mechanisms. Specifically, we find that higher levels of 
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placental CRH are associated with cortical thinning in selective brain regions and with 
decreased cognitive and emotional function in preadolescents.
Methods
All methods, human procedures and protocols were approved by the Institutional Review 
Boards of the Universities of California-Irvine and Los Angeles, and Cedars-Sanai Hospital, 
Los Angeles. Parents and children gave informed (or affirmed) consent for all aspects of the 
protocol.
Participants
Ninety–seven mother/child dyads consented to participate in a longitudinal study of fetal 
exposures to maternal stress hormones on child MRI (see Consort Diagram, Figure S1; 
Tables S1A-1C). Women provided informed consent to provide a blood sample at five 
intervals during gestation; 13.5–16.6 (M=15.3), 17.8–20.5 (M=19.2), 23.7–26.5 (M=24.9), 
29.9–32.3 (M=30.9) and 34.6–38.1 (M=35.9). All women were English-speaking, healthy 
adult (>18 years of age) pregnant women with singleton, intrauterine pregnancies. Subjects 
were excluded if they had (i) multiple births, (ii) tobacco, alcohol, or other drug use in 
pregnancy, (iii) uterine or cervical abnormalities, or (iv) presence of any conditions 
associated with dysregulated neuroendocrine function. Their children (48 boys, 49 girls) 
were enrolled at 6-9 years of age (M=7.3 ± 0.91). All participants provided written informed 
consent after receiving a complete description of the study.
Assessments of pCRH in pregnant women
Gestational age at testing was determined by last menstrual period and was confirmed by 
obstetric ultrasonographic biometry before 20 weeks. Maternal blood samples (20/ml) were 
collected serially at five intervals throughout pregnancy by antecubital venipuncture into 
siliconized ethylenediaminetetraacetic acid (EDTA) (purple top) vacutainers and then 
immediately chilled to 60C. Samples were centrifuged at 2,000 g for 15 minutes, decanted 
into polypropylene tubes prepared with aprotinin (Sigma Chemical, St. Louis, MO; 500 
KIU/ml blood) and stored at −80°C until assayed.
pCRH determination
Following previously reported methods (40), the concentration of total maternal pCRH was 
determined by radio-immunoassay (RIA; Bachem Peninsula Laboratories, San Carlos, CA). 
The CRH assay had less than 0.01% cross-reactivity with ovine CRH, 36% cross-reactivity 
with bovine CRH and non-detectable reactivity with human ACTH. The intra- and inter-
assay coefficient of variance ranged from 5 to 15%, respectively. The minimum detectable 
dose of the assay is 2.04 pg/ml (95% confidence interval; See Supplement for additional 
assay details).
Data reduction for the RIA was conducted with a computer-assisted four-parameter logistics 
program (41). Values exhibiting greater than 25% error (deviation from the standard curve) 
were not included in the analyses. A subset of samples (n = 60) were sent to a clinical 
laboratory (Quest Diagnostics) for further validation. The correlation between the two sets 
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of data was 0.87 (p < .01). Shared variance between 19 and 31 weeks CRH samples was a 
modest 14% (r=0.38). Mother/child dyads were recruited from two separate studies with 
identical prenatal assessments. To ensure comparability between the cohorts for analysis, the 
pCRH values were standardized within the two groups and then combined for statistical 
analysis. (see Supplement for details). As expected, pCRH levels increased geometrically as 
gestation advanced (Figure S4; Table S9).
Assessments in children
All children (ages 87.3 ± 10.9 mo) had a stable neonatal course (Median Apgar = 9, Range 8 
to 10; GA at birth=39.2 ± 1.5 wks) and were without known neonatal illness or congenital, 
chromosomal, or genetic anomalies. Participants had no evidence of neurological 
abnormalities in the newborn period. Children’s structural MRI (sMRI) images were 
assessed for normal anatomical appearance. Seven children with motion artifacts and three 
children with abnormal scans were not included in the final sample (N=97). These ten 
subjects did not differ from subjects providing useable scans (Table S8). At 6-9 years of age, 
no physical conditions were reported by the parents in a structured interview format of the 
MacArthur Health and Behavior Questionnaire (42). The majority (88%) of children were 
right hand dominant (Edinburgh Handedness Inventory) (43).
Structural MRI (sMRI) Acquisition
The sMRI scan was acquired with a 3-T Philips Achieva system. Children were provided 
earplugs and watched a movie while in the scanner to increase compliance and minimize 
movement. A high resolution T1 anatomical scan was acquired in the sagittal plane with 
1mm3 isotropic voxel dimensions. An Inversion-Recovery Spoiled Gradient Recalled 
Acquisition (IR-SPGR) sequence with optimal parameters was applied: repetition rate (TR)= 
11ms, echo time (TE)= 3.3ms, inversion time (TI)= 1100ms, turbo field echo factor (TFE)= 
192, number of slices: 150, no SENSE acceleration, flip angle=180°, shot interval (time 
from inversion pulse to the center of acquisition) = 2200ms. The images were reviewed by 
the MRI operator (who was unaware of any of the study parameters) immediately after the 
scan was completed. If there were visible signs of motion artifacts, the subject was asked to 
stay for an additional scan. If the subject agreed, a second scan was acquired.
Processing of MRI data
Cortical surface reconstruction and volumetric segmentation was performed with the 
FreeSurfer image analysis software suite (http://surfer.nmr.mgh.harvard.edu/). Streamlined 
image processing procedures included; application of intensity normalization prior to 
segmentation to minimize errors in identifying the boundaries (44); removal of non-brain 
tissues (45); and transforming images into the Talairach space. Pial and white matter 
surfaces were located by finding the highest intensity gradient. Surface inflation was applied 
to each individual brain (46) and the inflated brains were registered to a spherical atlas. 
Cortical thickness was the closest distance from the gray matter/white matter surface to the 
pial surface at each vertex on the tessellated surface (47).
Sandman et al. Page 4
Am J Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Assessment of percent of cortical areas affected by fetal exposure to pCRH
Smoothing of images was done prior to regression. The command line interface was used for 
FDR corrections and to accommodate more than one nuisance variable. Gestational age at 
birth, birth weight, age of the child at testing, sex and handedness were included as 
covariates. A threshold of p<0.05 was used for all statistical tests and outcomes were 
corrected for multiple comparisons using False Discovery Rate (FDR).
After FDR corrections and spatial normalization, the number of vertices that were 
significantly associated with pCRH was determined in each region of the cortex. The 
number of significant vertices for each area was added and divided by the total number of 
vertices in that area to provide the percentage of the vertices that were significantly 
associated with pCRH concentrations. The same procedure was computed for the number of 
significant vertices in each lobe. For hemispheric and whole brain percentages, the 
procedure was the same except the total number of subcortical vertices was subtracted from 
the total.
Child Behavioral Analyses
We conducted a battery of tests that interrogate several brain regions and circuits, to obtain a 
relatively broad assessment of cognitive and emotional function.
The Child Behavior Checklist (CBCL) (48) is one of the most widely used parental 
interviews for identifying affective and conduct disorder problems in children. Structured 
interviews (rather than a questionnaire) were administered to mothers about the behavior of 
their children. We focused on two inclusive scales; one that assessed Internalizing problems 
(sum of anxious-depressed, withdrawn-depressed, and somatic-complaints scores) and the 
other that evaluated externalizing problems (sums rule-breaking and aggressive behavior 
problem scores). Responses were recorded on a Likert scale ranging from 0 = Not True, to 2 
= Very True or Often True. Scores are summed and standardized scores are computed that 
are age and sex-specific.
Reaction time to incongruent stimuli
The “Flanker” is an executive function task that requires the ability to resolve conflicts when 
competing information is present (49). Participants view five arrows arrayed horizontally on 
a screen and are instructed to press a left or right response button based on the direction of 
the center arrow (target). They are instructed to ignore the surrounding arrows which are 
either congruent (all aligned in the same direction) or incongruent with the center arrow. 
This task consists of 24 congruent trials and 24 incongruent trials. Each set of arrows is 
presented until the child responds (maximum of 5000 msec) with a 750 msec inter-trial 
interval. Among the scores median reaction time to targets with incongruent distractors 
correlates most highly with other indexes of performance derived from this test (all r’s 
>0.70). (The association between externalizing scores on the CBCL and the median reaction 
time on the flanker test was not significant (r= 0.09, p=.41)
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RESULTS
Elevated CRH levels throughout gestation are associated with cortical thinning
Significant associations between fetal exposure to pCRH averaged across gestation and areas 
of cortical thinning in children were found as illustrated in the pial maps (Figure 1). 
Children exposed to high levels of pCRH throughout fetal life exhibited significant thinning 
in 12% of the whole cortical mantle (Table S2A). The anatomical distribution of the cortical 
thinning associated with CRH exposure involved equally the left (LH, 12%) and right (RH, 
11%) hemispheres (Table S2A). Regional analyses indicated that cortical thinning associated 
with pCRH levels was primarily in the temporal (15%) and the frontal (16%) regions (Table 
1). Figures 1B-D are illustrative scatterplots of the associations between total fetal exposure 
to pCRH across gestation and cortical thinning in the frontal and temporal areas (all 
significant p< 0.01-0.001). The representative scatterplots coupled with Table 1, highlight 
the widespread association between fetal exposures to pCRH and regional cortical thinning, 
which are most notable in temporal and frontal areas. Average concentrations of pCRH 
across gestation or levels at any gestational interval did not associate with increased cortical 
thickness either globally or in any cortical region (Table S2b). Focusing on two gestational 
ages, 19 weeks (early, when pCRH production begins to accelerate) and 31 weeks (late, the 
time strongly associated with preterm birth), we found that maternal levels of pCRH were 
significantly associated with cortical thinning.
CRH levels early in gestation: regional cortical thinning and behavioral outcomes
Fetal exposure to pCRH early in gestation (19 weeks) was associated with significant 
thinning of the frontal poles. The significant association between pCRH and cortical 
thinning was bilateral, but strongest in the right (B=0.14, p<0.001; 78% of the structure) 
compared with the left frontal pole (B=−6.88, p<0.05; 69% of the structure; Table S3). Pial 
maps depict areas of significant thinning linked with fetal pCRH exposure early in gestation 
(Figure 2A) and the scatterplots illustrate the regions of the frontal cortex with the strongest 
association (Figures 2B-D). (Findings were essentially unchanged with log transformed 
pCRH values, Table S5). Nearly identical associations were observed in a smaller subsample 
(N=57) of children exposed to high pCRH levels measured even earlier, at 15 weeks of fetal 
life (Figures S3A-D).
Thinning of the frontal pole has been associated with externalizing behaviors (50) defined as 
actions that direct energy outward and tend to harm others (51). We tested if the effects of 
pCRH exposure on cortical thinning contributed to the development of these behaviors 
(Figure 2E). Our model supported the belief that reduced cortical volume in the frontal pole, 
associated with elevated fetal exposure to concentrations of pCRH at 19 weeks gestation, 
contribute to externalizing symptoms in 6-9 year old children (indirect effect: 0.93; 95% 
BCCI 0.17 to 2.05; p < .05). Neither internalizing problems nor reaction time on the flanker 
task were associated with cortical thinning in this region.
CRH levels in late gestation: regional cortical thinning and cognitive outcomes
Exposure to elevated levels of pCRH later in gestation (31 weeks) was associated with 
cortical thinning in the lateral temporal and paracentral regions (Figure 3A). The effect was 
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localized to the left paracentral region and bilateral in the temporal cortex. Remarkably, 98% 
of the lateral surface of the right temporal pole and 66% of the left temporal pole were 
significantly thinner in children exposed to high levels of pCRH at 31 weeks gestation 
(Table S4). Scatterplots (Figure 3B-D) illustrate these regional associations (and similar 
associations were observed at 25 weeks gestation in a smaller subsample [N=50]).
Structures comprising the temporal cortex subserve numerous cognitive and emotional 
functions. Temporal cortical thinning has been reported in individuals with attentional 
deficits (52), especially in the right temporal pole (53) which is active in tasks requiring 
attention to relevant stimulation (54). We employed a statistical model (55) to test if the 
effects of exposure to pCRH late in prenatal life on cortical thinning contributed to 
impairment of attention in 6-9 year olds. The model (Figure 3E) indicated that the reduced 
right temporal pole volume associated with exposure to pCRH at 31 week gestation may 
partially account for poorer performance on a visual processing and sustained attention test 
(indirect effect: 42.11; 95% BCCI 4.27 to 128.31; p <0.01) (56,57).
Sex differences
Exploratory analyses suggest significant sex differences in the nature and degree of 
association between pCRH levels and global as well as regional cortical thinning. At both 19 
and 31 weeks gestation, the associations were stronger in girls (Figure S2). The association 
between fetal exposure to pCRH at 19 weeks gestation and cortical thinning involved most 
cortical areas in girls (Figure S2A) but minimal in boys (Figure S2B). The fetal exposure to 
pCRH at 31 weeks affected cortical thinning globally in boys (Figure S2C) but locally in the 
temporal pole in girls (Figure S2D; similar to the findings for the combined sexes).
DISCUSSION
The principal and novel findings in these series of studies are that human fetal exposure to 
pCRH, even at concentrations which are insufficient to initiate labor or early delivery, is 
associated with regional cortical thinning and commensurate cognitive and emotional 
problems in a sex-specific manner in school-age children. Notably, such problems often are 
prodromal events that are associated with eventual neuropsychiatric outcomes.
The human placenta expresses pCRH by the eighth week of gestation and concentrations of 
pCRH increase geometrically as pregnancy advances to regulate the timing and onset of 
labor and delivery (30,58). Indeed, extremely high levels of placental CRH, often a result of 
adverse events during pregnancy, stimulate a cascade of events that result in pre-term labor 
and delivery. Premature birth is a significant contributing factor to impaired neurological and 
psychiatric outcomes. However, pCRH levels also rise in response to a variety of maternal 
stresses, and the novel finding here is the profound consequence of fetal exposure to pCRH 
at levels that are not associated with early delivery, in full-term school-age children. 
Specifically, we identify pronounced thinning in discrete cortical areas with implications for 
emotional and cognitive functions. Pronounced cortical thinning was associated with fetal 
exposure to pCRH across gestation with some evidence of localization in prefrontal and 
temporal poles. Examination of discrete gestational intervals clarified that prefrontal 
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thinning was associated with exposure at early mid-gestation and thinning of the temporal 
pole was associated with exposure later in gestation.
Our findings raise the novel possibility that CRH is causally linked to cortical thinning, 
rather than merely signifying the presence of a harsh, stressful milieu to the developing fetal 
brain. A causal role for CRH in cortical thinning is supported by recent findings in an animal 
model (22). Cortical volume is largely comprised of dendritic trees of cortical neurons 
(22,59) and changes in dendritic arborization can be measured as volume loss in MR 
imaging (60). Our recent experiments demonstrate that exposure of developing cortical 
neurons to physiological levels of CRH results in a dose-dependent reduction and 
impoverishment of dendritic arborization (22). In addition, both exposure to early postnatal 
CRH in vivo (61) and to maternal stress signals (62,63) provokes similarly impoverished 
dendritic trees in the hippocampus. Indeed, exposure to nanomolar levels of CRH has been 
shown to reduce dendritic length and complexity via CRH receptor type 1 (64), which is 
expressed on the dendrites (65,66). Eliminating the actions of endogenous CRH led to 
exuberant dendritic trees both in transgenic mice lacking the CRH receptor and chronic 
exposure of organotypic slice cultures to CRH receptor blockers (64,65). Thus, it appears 
that the role of physiological levels of CRH is to modulate – perhaps in concert with 
glucocorticoids (67,68)– neuronal dendritic development in the perinatal hippocampus and 
neocortex.
The sex differences observed here are intriguing, and consistent with increased prevalence of 
stress-related disorders in women compared to men, tendencies observed also in prepubertal 
children (69). Our novel findings here suggest that sex-specific structural consequences of 
early-life adversity and potentially of CRH may be most apparent in females and are 
consistent with conclusions that females exposed to prenatal stress are more likely than 
males to exhibit increased levels of anxiety, impaired executive function and neurological 
markers associated with these behaviors (69).
In summary, our findings uncover a novel and unexpected result of prenatal elevation of 
pCRH: reduction in cortical volume in typically developing children, perhaps related to 
stunting of normal neuronal growth, and consequent commensurate subtle but significant 
emotional and cognitive impairments. The behavioral assessments were not a priori designed 
for assessing the unexpected cortical thinning observed in the temporal lobes, and this 
limitation should be addressed in future studies. Even when CRH levels are not sufficient to 
trigger premature birth and children are born at term, fetuses exposed to increased levels of 
pCRH carry less-well developed cortical neurons, apparent from extensive yet selective 
areas of cortical thinning. The cortical thinning is biologically significant because it is 
associated with both cognitive and emotional deficits.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. 
Pial maps (A) illustrating statistically significant areas of cortical thinning associated with 
average prenatal levels of pCRH measured throughout gestation. Representative scatterplots 
(B) r=0.37; (C) r=0.36; (D) r=0.26, all significant (p< 0.01-0.001), revealing the associations 
between placental corticotropin releasing hormone (CRH) and cortical thinning in specific 
cortical regions
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FIGURE 2. 
Pial maps (A) illustrating statistically significant areas of cortical thinning associated with 
prenatal levels of pCRH at 19 weeks gestation. Representative scatterplots (B [r=.33, p=.
005] C [r=.25, p=.04], D [r=.40, p=.001]) of the significant associations between pCRH and 
cortical thinning in cortical subregions. Model (E) of the indirect significant association 
among prenatal concentrations of pCRH, child cortical thinning in the frontal pole and child 
internalizing behavior. The values correponding to each path in the model are 
unstandardized regression coefficients. The indirect effect was estimated with bootstrapping 
(1000 samples with replacement).
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FIGURE 3. 
Pial maps (A) from FreeSurfer illustrating statistically significant areas of cortical thinning 
associated with prenatal levels of pCRH at 31 weeks gestation. Representative scatterplots 
(B [r=.29, p=.01] C [r=.37, p=.001], D [r=.48, p=.001]) of the significant associations 
between pCRH and cortical thinning in cortical subregions. Model (E) of the indirect 
association among prenatal concentrations of pCRH, child cortical thinning in the right 
temporal pole and child reaction time to a behavioral challenge. The values correponding to 
each path in the model are unstandardized regression coefficients. The indirect effect was 
estimated with bootstrapping (1000 samples with replacement).
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Table 1
Percentage of structures of the frontal and temporal lobes that are thinner in children exposed to placental 
CRH averaged across gestation. The results are presented for the left and right hemisphere.
AVERAGE ACROSS GESTATION
LH Medial Surface Frontal Percent of Structure RH Medial Surface Frontal Percent of Structure
Orbital Frontal 11 Orbital Frontal 19
Paracentral 43 Paracentral 14
LH Lateral Surface Frontal Percent of Structure RH Lateral Surface Frontal Percent of Structure
Superior Frontal 13 Superior Frontal 44
Rostral Middle Frontal 12 Rostral Middle Frontal 14
Frontal Pole 41 Frontal Pole 33
Pars Triangularis 16 Pars Triangularis 21
Parsorbitalis 6 Parsorbitalis 5
Lateral Orbital Frontal 15 Lateral Orbital Frontal 25
Parsopercularis 9 Parsopercularis 22
Caudal Middle Frontal 4 Caudal Middle Frontal 23
Precentral 18 Precentral 20
Insula 11 Insula 8
LH Lateral Surface Temporal Percent of Structure RH Lateral Surface Temporal Percent of Structure
Superior Temporal 39 Superior Temporal 12
Transverse Temporal 0 Transverse Temporal 0
Middle Temporal 22 Middle Temporal 24
Post Sup Temp sulcus 16 Post Sup Temp sulcus 0
Inferior Temporal 3 Inferior Temporal 12
Fusiform 7 Fusiform 2
Parahippocampal 11 Parahippocampal 0
Entorhinal 31 Entorhinal 0
Temporal Pole 4 Temporal Pole 70
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